Financial statements Apteka Sigma
Balance sheet data of APTEKA SIGMA
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 168 370,60 | 159 935,29 | 125 281,32 | 104 559,87 | 119 444,12 | 158 078,55 |
A. Fixed assets | 2 030,92 | 748,24 | 0,00 | - | - | - |
B. Current assets | 166 339,68 | 159 187,05 | 125 281,32 | 104 559,87 | 119 444,12 | 158 078,55 |
C. Share capital contributions (basic funds) | - | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - | - |
Total liabilities | 168 370,60 | 159 935,29 | 125 281,32 | 104 559,87 | 119 444,12 | 158 078,55 |
A. Equity | 99 634,29 | 84 241,60 | 60 068,61 | 44 052,88 | 33 826,47 | -3 779,25 |
B. Liabilities and provisions for liabilities | 68 736,31 | 75 693,69 | 65 212,71 | 60 506,99 | 85 617,65 | 161 857,80 |
I. Long-term liabilities | - | - | - | - | - | - |
II. Short-term liabilities | 68 736,31 | 75 693,69 | 65 212,71 | 60 506,99 | 85 617,65 | 161 857,80 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.